ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
This study focuses on Mycosis Fungoides (MF) and Sezary Syndrome (SS), which are specific types of Non-Hodgkin's Lymphoma that primarily affect the skin. Researchers want to gather information from patients with these conditions to create a tool that helps predict how the disease might progress. By understanding which patients might be at higher or lower risk for certain outcomes, doctors can improve the way they plan and deliver care. The goal is to collect detailed and consistent information from many different hospitals to build a more accurate picture, ultimately leading to better support and treatment strategies for people living with these rare conditions.
Auf einen Blick
Worum geht es in dieser Studie?
This study is looking into two rare types of lymphoma that mainly affect the skin: Mycosis Fungoides (MF) and Sezary Syndrome (SS). These conditions are types of Non-Hodgkin's Lymphoma. The main idea behind this research is to get a better understanding of how these diseases behave in different people.
To do this, doctors and researchers at various hospitals will collect information from patients with these conditions. They want to look at lots of different factors – things like specific symptoms, how quickly the disease has changed, and how it responds to initial treatments. By gathering this consistent information from many patients, they hope to find patterns.
The ultimate goal is to create a kind of prediction tool. This tool would help doctors identify early on whether a patient might have a more aggressive form of the disease or a milder one. Knowing this could help doctors tailor treatments more effectively and improve the personal care plan for each patient. It’s all about working towards better ways to manage and treat MF and SS.
Wichtige Erkenntnisse
- A research study focused on understanding Mycosis Fungoides (MF) and Sezary Syndrome (SS).
- Aims to identify factors that predict how the conditions might progress.
- Data collection from existing medical records to improve future patient care.
- Not a treatment study; no new medications or procedures involved.
- Information gathered will be kept private and confidential.
Wer könnte berechtigt sein?
To be part of this study, you would need to have been diagnosed with a more advanced stage of Mycosis Fungoides or Sezary Syndrome (Stages IIB through IVB). This diagnosis must have been made within the last six months before you first came to the hospital taking part in the study.
It's also important that you plan to continue receiving your care at the hospital involved in the study, or that the doctors can easily keep track of your health if you're also seeing another doctor. This ensures they can collect all the necessary information about your health over time.
You would not be able to join if you were diagnosed with an earlier stage of MF or SS (Stages IA-IIA) and your disease later became more advanced. Also, if your advanced diagnosis was made more than six months before you first visited the participating hospital, you wouldn't qualify. Finally, this study isn't for people who are just coming for a single visit and won't be continuing their care at the study hospital.
Könnte diese Studie für Sie geeignet sein?
Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.
- Have I been diagnosed with advanced Mycosis Fungoides (MF) or Sezary Syndrome (SS)?
- Was my advanced diagnosis made within the last 6 months before my first visit to the study hospital?
- Do I plan to receive my ongoing care at the hospital involved in the study?
- Have I NOT been diagnosed with an early stage MF/SS that later became advanced?
Was beinhaltet die Teilnahme?
As this study is about collecting information for research, you wouldn't be asked to take any new medication or have any extra medical procedures. Your participation would mainly involve allowing the research team to collect information from your existing medical records, such as your diagnosis, symptoms, and how you are responding to your usual care. This information would be collected during your regular hospital visits for managing your condition.
Potenzielle Risiken und Vorteile
Standorte (13)
- Stadt der HoffnungVerifizierte PostleitzahlDuarte, Vereinigte Staaten· Rekrutierung
- Stanford University, School of MedicineVerifizierte PostleitzahlPalo Alto, Vereinigte Staaten· Rekrutierung
- Universität von IowaVerifizierte PostleitzahlIowa City, Vereinigte Staaten· Rekrutierung
- Hackensack UniversitätsklinikumVerifizierte PostleitzahlHackensack, Vereinigte Staaten· Rekrutierung
- University of PittsburgVerifizierte PostleitzahlPittsburgh, United States· Rekrutierung
- University of Texas SouthwesternVerifizierte PostleitzahlDallas, Vereinigte Staaten· Rekrutierung
- University of Utah HospitalVerifizierte PostleitzahlSalt Lake City, Vereinigte Staaten· Rekrutierung
- Hospital Italiano de Buenos AiresVerifizierte PostleitzahlBuenos Aires, Argentina· Rekrutierung
- Peter MacCallum Cancer Center,Verifizierte PostleitzahlMelbourne, Australia· Rekrutierung
- University of Sao Paulo Medical SchoolVerifizierte PostleitzahlSão Paulo, Brazil· Rekrutierung
- Peking University First HospitalVerifizierte PostleitzahlPeking, China· Rekrutierung
- The University of TokyoVerifizierte PostleitzahlTokyo, Japan· Rekrutierung
Häufige Fragen
What are Mycosis Fungoides (MF) and Sezary Syndrome (SS)?
They are rare types of lymphoma, a form of cancer that usually starts in white blood cells. These specific types mainly affect the skin.
Was ist das Hauptziel dieser Studie?
The study aims to understand what factors can predict how MF/SS might progress in different people, which can help doctors provide more personalised care.
Will I receive new treatments if I join this study?
No, this study is about gathering information from existing medical records and your regular care, not testing new treatments or medications.
Will my personal health information be kept private?
Yes, all your personal information collected for the study will be handled with strict privacy and kept confidential.
How does this study help patients?
By identifying patterns, researchers hope to create a tool that helps doctors better understand individual risks in MF/SS, potentially leading to improved care for future patients.
Wie Sie mehr erfahren können
Tatiana Neal
Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.
Interessiert daran, teilzunehmen?
Diskussion
Community-Diskussion
Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.